What is in it for my patient? Moving beyond short-term benefits and risks for recently approved DMTs in MS
25 November 2021

What is in it for my patient? Moving beyond short-term benefits and risks for recently approved DMTs in MS

Join Prof. Gavin Giovannoni, Prof. David Baker and Prof. Sonia Batista for the next interactive multiple sclerosis seminar of Janssen’s Neuroscience Medical Education (NSME) Forum. Here, the faculty will reflect on the therapeutic potential of new disease-modifying therapies (DMTs) for MS and discuss based on clinical scenarios what it means for patients in practice. This ...

more info...

EM-72360
Managing MDD in psychiatric emergencies: current strategies and practical insights
16 September 2021 - 57 Minutes

Managing MDD in psychiatric emergencies: current strategies and practical insights

Learning objectives:

After attending this webinar, participants should be able to:

  • Describe the considerations for management of patients experiencing a psychiatric emergency due to MDD
  • Describe the available data for current treatments for patients experiencing a psychiatric emergency due to MDD, including new fast-acting antidepressants
  • Describe the practical aspects and associated considerations of managing patients experiencing ...
more info...

EM-64170
MS highlights from the EAN congress 2021
1 July 2021 - 61 Minutes

MS highlights from the EAN congress 2021

Join Professor Iris-Katharina Penner, Professor Frederik Barkhof and Professor Jeremy Chataway for the third interactive multiple sclerosis (MS) seminar of Janssen’s Neuroscience Medical Education (NSME) Forum for a unique opportunity to discuss specially selected MS highlights from the 7th Congress of the European Academy of Neurology (EAN). This is a continuation of a new interdisciplinary and interactive series providing the opportunity ...

more info...

EM-62443
Managing MDD in psychiatric emergencies: how to undertake risk assessment
24 June 2021 - 59 Minutes

Managing MDD in psychiatric emergencies: how to undertake risk assessment

Learning objectives:

After attending this webinar, participants should be able to:

  • Describe the burden of MDD in psychiatric emergencies and the need for rapid intervention
  • Describe the assessment of risk in patients with MDD in psychiatric emergencies, and the associated challenges

 

Faculty:

  • Fintan Larkin, co-chair
  • Maurizio Pompili, co-chair
  • Philippe Courtet
more info...

EM-59505
MS and COVID-19 vaccination: What do we have to consider?
26 May 2021 - 45 Minutes

MS and COVID-19 vaccination: What do we have to consider?

Join Professor Frauke Zipp and Professor Gregory Poland for the second interactive multiple sclerosis (MS) seminar of Janssen’s Neuroscience Medical Education (NSME) Forum for a unique opportunity to discuss the implications of the COVID-19 vaccines with a vaccine expert. This is a continuation of a new interdisciplinary and interactive series providing the opportunity to gain valuable insights from leading experts ...

more info...

EM-60507
EPA 2021 highlights: insights into recent developments in MDD and relevance for clinical practice
13 April 2021 - 57 Minutes

EPA 2021 highlights: insights into recent developments in MDD and relevance for clinical practice

Learning objective:

After attending this webinar, participants should be able to:

  • Discuss what recent research presented at the EPA 2021 congress could mean for clinical practice in MDD

 

Faculty:

  • Kamilla Miskowiak, Denmark (Chair)
  • Eduard Vieta, Spain
  • Mazda Adli, Germany
more info...

EM-54602
Management of MDD and TRD: advances in treatment optimisation and digital healthcare
10 April 2021 - 90 Minutes

Management of MDD and TRD: advances in treatment optimisation and digital healthcare

Janssen-supported satellite symposium at EPA Virtual 2021

Industry satellite symposium supported by Janssen Pharmaceutica NV, first presented at the virtual edition of the 29th European Congress of Psychiatry 10th-13th April 2021.

This satellite symposium will be available for on-demand viewing soon after first presentation.  Please subscribe via the button to receive an e-mail notification once the on-demand version is available.

 

Learning objective:

After attending this symposium, participants should ...

more info...

EM-49856
What lessons have we learned from the COVID-19 pandemic for the management of patients with MS?
23 March 2021 - 44 Minutes

What lessons have we learned from the COVID-19 pandemic for the management of patients with MS?

Join Prof. Comi and Prof. Leocani for a discussion of best practices for managing the ongoing treatment and rehabilitation of patients with MS in the COVID-19 era. The COVID-19 pandemic has changed how HCPs can engage with their patients dramatically. In this interactive seminar, Prof. Comi and Prof. Leocani want to reflect on the impact ...

more info...

EM-52608
Management of depression and escalation strategies: who, when and how?
18 February 2021 - 59 Minutes

Management of depression and escalation strategies: who, when and how?

Learning objectives  

After attending this webinar, participants should be able to:

  • Describe the ways in which patient management may be optimised in TRD
  • Describe the available escalation strategies for patients with TRD, including when they should be used and for whom they are suitable
  • Describe the methods by which individualised patient management may be achieved in TRD

 

Faculty

    ...

more info...

EM-49980
Towards a personalised approach in TRD management: clinician and patient perspectives
10 December 2020 - 65 Minutes

Towards a personalised approach in TRD management: clinician and patient perspectives

Join our expert faculty for this webinar focussing on clinician and patient perspectives in the management of treatment-resistant depression. The webinar will include two engaging and informative presentations on the importance of full functional recovery and phenotyping in patients with depression, and patient centricity in patient-reported outcomes and outcome scales. This will be followed by a live discussion between clinician and ...

more info...

EM-45438
;